These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31299954)

  • 1. Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).
    Cruz T; López-Giraldo A; Noell G; Casas-Recasens S; Garcia T; Molins L; Juan M; Fernandez MA; Agustí A; Faner R
    Respir Res; 2019 Jul; 20(1):152. PubMed ID: 31299954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of dendritic cell co-stimulation in COPD.
    Stoll P; Ulrich M; Bratke K; Garbe K; Virchow JC; Lommatzsch M
    Respir Res; 2015 Feb; 16(1):19. PubMed ID: 25775429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease.
    Mori M; Andersson CK; Svedberg KA; Glader P; Bergqvist A; Shikhagaie M; Löfdahl CG; Erjefält JS
    Thorax; 2013 Jun; 68(6):521-31. PubMed ID: 23412435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.
    Faner R; Morrow JD; Casas-Recasens S; Cloonan SM; Noell G; López-Giraldo A; Tal-Singer R; Miller BE; Silverman EK; Agustí A; Hersh CP
    Respir Res; 2019 Jan; 20(1):5. PubMed ID: 30621695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and Th17/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease.
    Zheng X; Zhang L; Chen J; Gu Y; Xu J; Ouyang Y
    Biomed Pharmacother; 2018 Dec; 108():1141-1151. PubMed ID: 30372815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow characterization in COPD: a multi-level network analysis.
    Toledo-Pons N; Noell G; Jahn A; Iglesias A; Duran MA; Iglesias J; Rios A; Scrimini S; Faner R; Gigirey O; Agustí A; Cosío BG
    Respir Res; 2018 Jun; 19(1):118. PubMed ID: 29903047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients.
    Olloquequi J; Montes JF; Prats A; Rodríguez E; Montero MA; García-Valero J; Ferrer J
    Eur Respir J; 2011 Feb; 37(2):289-98. PubMed ID: 20525712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
    Rinaldi M; Lehouck A; Heulens N; Lavend'homme R; Carlier V; Saint-Remy JM; Decramer M; Gayan-Ramirez G; Janssens W
    Thorax; 2012 Aug; 67(8):694-700. PubMed ID: 22442201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced activation of circulating plasmacytoid dendritic cells in patients with Chronic Obstructive Pulmonary Disease and experimental smoking-induced emphysema.
    Qiu SL; Kuang LJ; Tang QY; Duan MC; Bai J; He ZY; Zhang JQ; Li MH; Deng JM; Liu GN; Zhong XN
    Clin Immunol; 2018 Oct; 195():107-118. PubMed ID: 29127016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.
    Bracke KR; D'hulst AI; Maes T; Moerloose KB; Demedts IK; Lebecque S; Joos GF; Brusselle GG
    J Immunol; 2006 Oct; 177(7):4350-9. PubMed ID: 16982869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation or suppression? T cell immunity in COPD lungs.
    Clambey ET; Torres RM
    COPD; 2009 Apr; 6(2):84-5. PubMed ID: 19378220
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.
    Hueper K; Vogel-Claussen J; Parikh MA; Austin JH; Bluemke DA; Carr J; Choi J; Goldstein TA; Gomes AS; Hoffman EA; Kawut SM; Lima J; Michos ED; Post WS; Po MJ; Prince MR; Liu K; Rabinowitz D; Skrok J; Smith BM; Watson K; Yin Y; Zambeli-Ljepovic AM; Barr RG
    Am J Respir Crit Care Med; 2015 Sep; 192(5):570-80. PubMed ID: 26067761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
    Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
    Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
    Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
    Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
    Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
    King PT; Lim S; Pick A; Ngui J; Prodanovic Z; Downey W; Choong C; Kelman A; Baranyai E; Francis M; Moshinsky R; Bardin PG; Holmes PW; Holdsworth SR
    J Allergy Clin Immunol; 2013 May; 131(5):1314-21.e14. PubMed ID: 23142009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.
    Calabrese F; Baraldo S; Bazzan E; Lunardi F; Rea F; Maestrelli P; Turato G; Lokar-Oliani K; Papi A; Zuin R; Sfriso P; Balestro E; Dinarello CA; Saetta M
    Am J Respir Crit Care Med; 2008 Nov; 178(9):894-901. PubMed ID: 18703789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
    Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
    Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
    Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.